病毒战士:释放免疫系统的潜力与癌症免疫疗法在癌症免疫治疗中的瘤病毒
Reza Ghavimi1,2, Leila Rahimian1,2, Mohsen Mohammadi3
1Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.
Molecular therapy. Oncology
|December 24, 2025
概括
瘤解毒病毒 (OVs) 旨在破坏癌细胞,释放瘤抗原以刺激免疫反应. 这些病毒可以将"冷"瘤转化为"热"瘤,提高免疫治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 在瘤学瘤学.
背景情况:
- 瘤病毒 (OV) 是一种有前途的癌症免疫治疗方法.
- 卵巢病毒选择性地感染和溶解瘤细胞,刺激抗瘤免疫反应.
- 它们可以被设计成增强免疫增强因子分泌.
研究的目的:
- 审查癌症治疗中OVs的历史,机制和组合策略.
- 突出OVs在改变瘤微环境 (TME) 的潜力.
- 讨论涉及OVs的挑战和临床试验.
主要方法:
- 关于OV研究,机制和临床应用的文献综述.
- 对OV介导的瘤细胞溶解和抗原呈现的分析.
- 检查OV对瘤微环境 (TME) 和免疫细胞透的影响.
主要成果:
- 由OV诱导的瘤细胞溶解释放瘤特异性抗原 (TAA),作为一种局部疫苗.
- 卵巢病毒刺激先天性和适应性免疫,增强抗瘤反应.
- OVs可以将免疫学上"冷"的瘤转化为"热"的瘤,提高免疫疗法的疗效.
结论:
- 卵巢病毒为癌症免疫疗法提供了一个多功能平台,有可能与其他治疗方法产生协同效应.
- 将TME从"冷"重新编程到"热"是OV成功的关键机制.
- 进一步的研究和临床试验至关重要,以充分实现OVs的治疗潜力.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
926
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


